199 related articles for article (PubMed ID: 31795352)
1. Preparation of Polyethylene Glycol-Ginsenoside Rh1 and Rh2 Conjugates and Their Efficacy against Lung Cancer and Inflammation.
Mathiyalagan R; Wang C; Kim YJ; Castro-Aceituno V; Ahn S; Subramaniyam S; Simu SY; Jiménez-Pérez ZE; Yang DC; Jung SK
Molecules; 2019 Nov; 24(23):. PubMed ID: 31795352
[TBL] [Abstract][Full Text] [Related]
2. Protopanaxadiol aglycone ginsenoside-polyethylene glycol conjugates: synthesis, physicochemical characterizations, and in vitro studies.
Mathiyalagan R; Kim YJ; Wang C; Jin Y; Subramaniyam S; Singh P; Wang D; Yang DC
Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1803-1809. PubMed ID: 26539976
[TBL] [Abstract][Full Text] [Related]
3. In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: in vitro cytocompatibility studies.
Singh P; Kim YJ; Singh H; Ahn S; Castro-Aceituno V; Yang DC
Int J Nanomedicine; 2017; 12():4073-4084. PubMed ID: 28603419
[TBL] [Abstract][Full Text] [Related]
4. Preliminary study on fabrication, characterization and synergistic anti-lung cancer effects of self-assembled micelles of covalently conjugated celastrol-polyethylene glycol-ginsenoside Rh2.
Li P; Zhou X; Qu D; Guo M; Fan C; Zhou T; Ling Y
Drug Deliv; 2017 Nov; 24(1):834-845. PubMed ID: 28532223
[TBL] [Abstract][Full Text] [Related]
5. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of ginsenoside compound K using TPGS/PEG-PCL mixed micelles for effective treatment of lung cancer.
Yang L; Zhang Z; Hou J; Jin X; Ke Z; Liu D; Du M; Jia X; Lv H
Int J Nanomedicine; 2017; 12():7653-7667. PubMed ID: 29089761
[TBL] [Abstract][Full Text] [Related]
7. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Nag M; Gajbhiye V; Kesharwani P; Jain NK
Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
[TBL] [Abstract][Full Text] [Related]
8. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study.
Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M
Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside compound K-bearing glycol chitosan conjugates: synthesis, physicochemical characterization, and in vitro biological studies.
Mathiyalagan R; Subramaniyam S; Kim YJ; Kim YC; Yang DC
Carbohydr Polym; 2014 Nov; 112():359-66. PubMed ID: 25129755
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Proteomics Combined with Affinity MS Revealed the Molecular Mechanism of Ginsenoside Antitumor Effects.
Wang Z; Kim U; Jiao Y; Li C; Guo Y; Ma X; Jiang M; Jiang Z; Hou Y; Bai G
J Proteome Res; 2019 May; 18(5):2100-2108. PubMed ID: 30860844
[TBL] [Abstract][Full Text] [Related]
11. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
12. Investigating the Anticancer Activity of G-Rh1 Using In Silico and In Vitro Studies (A549 Lung Cancer Cells).
Nahar J; Boopathi V; Murugesan M; Rupa EJ; Yang DC; Kang SC; Mathiyalagan R
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500403
[TBL] [Abstract][Full Text] [Related]
13. Minor Ginsenoside Rg2 and Rh1 Attenuates LPS-Induced Acute Liver and Kidney Damages via Downregulating Activation of TLR4-STAT1 and Inflammatory Cytokine Production in Macrophages.
Huynh DTN; Baek N; Sim S; Myung CS; Heo KS
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932915
[TBL] [Abstract][Full Text] [Related]
14. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
15. Novel multiarm polyethylene glycol-dihydroartemisinin conjugates enhancing therapeutic efficacy in non-small-cell lung cancer.
Dai L; Wang L; Deng L; Liu J; Lei J; Li D; He J
Sci Rep; 2014 Jul; 4():5871. PubMed ID: 25070490
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside-Rh1 and Rh2 inhibit the induction of nitric oxide synthesis in murine peritoneal macrophages.
Park YC; Lee CH; Kang HS; Kim KW; Chung HT; Kim HD
Biochem Mol Biol Int; 1996 Nov; 40(4):751-7. PubMed ID: 8950033
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rh2 Inhibits Migration of Lung Cancer Cells under Hypoxia
Chen Y; Zhang Y; Song W; Zhang Y; Dong X; Tan M
Anticancer Agents Med Chem; 2019; 19(13):1633-1641. PubMed ID: 31272362
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rh2 mediates changes in the microRNA expression profile of human non-small cell lung cancer A549 cells.
An IS; An S; Kwon KJ; Kim YJ; Bae S
Oncol Rep; 2013 Feb; 29(2):523-8. PubMed ID: 23152132
[TBL] [Abstract][Full Text] [Related]
19. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
